Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

A modified uronic acid carbazole reaction

1962 • 6,191 citations

Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans

1992 • 1,095 citations

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1977 • 798 citations

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1992 • 749 citations

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

1981 • 685 citations

A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies

1991 • 557 citations

A cascade model for restenosis. A special case of atherosclerosis progression.

1992 • 447 citations

Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.

1981 • 443 citations

Cell biology of arterial proteoglycans.

1989 • 409 citations

Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis

1985 • 366 citations

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

1990 • 256 citations

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.

1985 • 210 citations

Smooth muscle cell expression of extracellular matrix genes after arterial injury.

1994 • 200 citations

Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state.

1989 • 170 citations

Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.

1993 • 134 citations

Patterns of sulphation in heparan sulphate: Polymorphism based on a common structural theme

1992 • 133 citations

Balloon catheter injury to rabbit carotid artery. I. Changes in smooth muscle phenotype.

1989 • 131 citations

Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis.

1994 • 102 citations

Combined Alcian Blue and Silver Staining of Subnanogram Quantities of Proteoglycans and Glycosaminoglycans in Sodium Dodecyl Sulfate-Polyacrylamide Gels

1993 • 96 citations

Syndecan-4 Is a Primary-Response Gene Induced by Basic Fibroblast Growth Factor and Arterial Injury in Vascular Smooth Muscle Cells

1997 • 91 citations

Endothelial Heparan Sulfate Proteoglycan. I. Inhibitory Effects on Smooth Muscle Cell Proliferation

1990 • 89 citations

Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.

1984 • 78 citations

Biosynthesis of Heparin and Heparan Sulfatea

1989 • 77 citations

Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit

1991 • 73 citations

Proteoglycans in Cell Regulation

1992 • 72 citations

Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation

1989 • 63 citations

Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype

1992 • 59 citations

The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial

1995 • 59 citations

Differential expression of transmembrane proteoglycans in vascular smooth muscle cells.

1993 • 57 citations

Cell-associated proteoheparan sulfate from bovine arterial smooth muscle cells

1988 • 50 citations

Paradoxical increase in restenosis rate with chronic heparin use: Final results of a randomized trial

1991 • 49 citations

Expression of growth factor receptors on arterial smooth muscle cells. Dependency on cell phenotype and serum factors

1995 • 44 citations

Localized Release of Perivascular Heparin Inhibits Intimal Proliferation after Endothelial Injury without Systemic Anticoagulation

1989 • 44 citations

Sustained-release of urease from a poloxamer gel matrix.

1990 • 43 citations

Mapping of proteoglycans in atherosclerotic lesions

1990 • 39 citations

Mapping of proteoglycans in human arterial tissue.

1987 • 39 citations

Biosynthesis of Heparin and Heparan Sulfate

1987 • 31 citations

Heparin-Induced Overexpression of Basic Fibroblast Growth Factor, Basic Fibroblast Growth Factor Receptor, and Cell-Associated Proteoheparan Sulfate in Cultured Coronary Smooth Muscle Cells

1996 • 26 citations

Isolation of heparin-insensitive aortic smooth muscle cells. Growth and differentiation.

1993 • 25 citations

Repeated Balloon Injury of Rat Aorta

1997 • 22 citations

Restenosis after angioplasty.

1990 • 14 citations

Bovine arterial smooth muscle cells synthesize two functionally different proteoheparan sulfate species

1990 • 13 citations

Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall

1995 • 11 citations

Subendothelial extracellular-matrix heparan sulfate proteoglycandegrading activity of human monocyte macrophages

1987 • 9 citations

Sulfated proteoglycans of rabbit aorta: Selective extraction and alternative method for glycosaminoglycan moiety analysis

1992 • 4 citations